Global Biological Safety Testing Market – Overview

The global market for biological safety testing is projected to exhibit a massive growth in the coming few years of the forecast period. There are multiple factors that are responsible for the overall development of the global biological safety testing market. One of the key driving factors for market growth has been their growing use in the biotechnology and pharmaceutical industries. Some of the other important driving factors for the growth of the global market are recent growth in the geriatric population, increasing awareness towards medicare and healthcare in developing economies, and growing prevalence of cancer across the globe.

The global biological safety devices market is projected to exhibit a massive CAGR of 10.0% during the course of the given forecast period of 2016 to 2024. The market is driven by the constant developments in terms of assistive technologies and increasing geriatric population. With these development factors, the global biological safety testing market is expected to reach a valuation of US$3.08 bn by the fall of 2024. Initially, the global market was valued at US$1.31 bn in 2015.

biological safety testing market

Segment of Reagents and Kits to Witness Promising Growth Due to Introduction of Innovative Technologies

Depending on the application, the global biological safety devices can be divided into cellular therapy, gene therapy, stem cell products, tissue & tissue products, blood & blood products, and vaccines & therapeutics. Of these, the global market for biological safety devices has been dominated by the segment of blood & blood products. The segment accounted for around 52.7% of the overall market share in 2015.

In terms of product, the global biological safety devices market has been dominated by the segment of instruments. The segment accounted for around 29.2% of the overall market share of the global biological safety devices market in 2015. The segment comprises of different types of products such as laboratory centrifuges, autoclaves, and biological safety cabinets (class I, class II, and class III) among others. The product segment is projected to experience a moderate development in the coming years of the given forecast period in comparison with the segment of reagents & kits. The high development of the kits segment is because of the growing popularity and introduction of more efficient and innovative technologies by the leading companies operating in the global market.

Latin America to Emerge as Promising Segment With Increasing Awareness about Healthcare and Presence of Leading Manufacturers

In terms of regional segmentation, the global biological safety devices market is divided into five main segments. These regional segments are North America, Latin America, Middle East and Africa, Asia Pacific, and Europe. Of these, the global biological safety devices market is currently dominated by the regional segment of North America. The region accounted for the largest share in the global market of around 42.2%. Europe is the next biggest regional segment of the biological safety devices market. On the other hand, the regional segment of Asia Pacific is the most promising and fastest growing one, whereas the Latin America market is projected to present with most lucrative opportunities. The growth of the Latin America market is due to the growing awareness about these biological safety devices and increasing presence of leading manufacturers in the region.

The competitive landscape of the global biological safety devices market is fragmented one. This fragmentation is because of the presence of several key players operating in the market. Some of the notable names in the global biological safety devices market are NuAire, Paragon Bioservices Inc., Nordic Scientific & Natural Solutions, Toxikon Inc., and SGS SA among others.

Global Biological Safety Testing Market: Overview

This report on biological safety testing market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various biological safety testing instrument and products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global biological safety testing market with respect to the leading market segments based on major products, applications and geographies.

Global Biological Safety Testing Market: Key Segments

The global biological safety testing market is divided into: by product, by test type, by application and by geography. Product type segment of tissue market was divided into instruments and reagents & kits. On the basis of test type the biological safety testing market is classified as Endotoxin Tests, Sterility Tests, Cell Line Authentication and Characterization Tests, Bioburden Tests, Residual Host Contaminant Detection Tests, Adventitious Agent Detection Tests, Other Tests (Toxicity tests, Stability tests, etc.). On the basis of application the biological safety testing market is classified as Vaccines & Therapeutics, Blood & Blood Products, Tissue & Tissue Products, Stem Cell Products, Gene Therapy, and Cellular Therapy. Vaccines & Therapeutics and Blood & Blood Products.

The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2016 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2016 as the base year.

Global Biological Safety Testing Market: Scope of the Report

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global biological safety testing market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products/materials/technologies/end-users/geographies. The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the report. The section also includes completion matrix that analyzes the competition among some of the top global players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Global Biological Safety Testing Market: Regional Outlook

Geographically, the biological safety testing market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for biological safety testing market has been further categorized into major product, applications, material, and end-user segments considered within the scope of the study. Key country (U.S., Canada, Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn and volume in terms of units for the period from 2014 to 2025 along with CAGR % from 2016 to 2025 are provided for all the regions and nations considering 2016 as the base year.

Companies Mentioned in the Report

The report profiles key manufacturers in the biological safety testing market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include Thermo Fisher Scientific Inc., Charles River Laboratories International, Inc., Merck KGaA, Lonza Group, Avance Biosciences, SGS SA, WuXi PharmaTech (Cayman) Inc., Toxikon, Inc., Nordic Scientific & Natural Solutions AB, Paragon Bioservices, Inc., and NuAire.

The global Biological safety testing market has been segmented as follows:

by Product Type

  • Instruments
    • Biological Safety Cabinet (class I, class II, class III)
    • Autoclaves
    • Laboratory Centrifuges
    • Others
  • Reagent & Kits

by Test Type

  • Endotoxin Tests
  • Sterility Tests
  • Cell Line Authentication and Characterization Tests
  • Bioburden Tests
  • Residual Host Contaminant Detection Tests
  • Adventitious Agent Detection Tests
  • Other Tests (Toxicity tests, Stability tests, etc.)

By Application

  • Vaccines & Therapeutics
  • Blood & Blood Products
  • Tissue & Tissue Products
  • Stem Cell Products
  • Gene Therapy
  • Cellular Therapy

by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Spain
    • Italy
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of MEA

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Biological Safety Testing Market

Buy Now